CLEAR + BRILLIANT LASER SYSTEM
Report
- Report Number
- 3011423170-2024-00168
- Event Type
- Injury
- Date Received
- June 8, 2024
- Date of Event
- May 8, 2024
- Report Date
- May 10, 2024
- Manufacturer
- SOLTA MEDICAL, INC
- Product Code
- ONG
- UDI-DI
- 00850608002643
- PMA / PMN Number
- K120433
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE CLEAR + BRILLIANT TREATMENT TIPS DO NOT DELIVERY ANY ENERGY AND NO TREATMENT DATA IS STORED ON THE TIP ITSELF; THERE IS NO INFORMATION TO GATHER FROM THEIR RETURN. THE EXCEPTION TO THIS WOULD BE IF THE CLEAR + BRILLIANT TIP PLASTIC HOUSING OR COMPONENT SCRATCHED THE PATIENT. FOR OTHER REPORTED EVENTS, TIPS ARE NOT A VIABLE SOURCE OF EVALUATION DATA. THE SYSTEM HAS NO SYSTEM/DATA LOGS THAT CAN BE REVIEWED. THE END-USER DID NOT AND DOES NOT PERFORM THE BURN PATTERN PAPER TESTS. IT WAS RECOMMENDED THAT THIS ACTION BE PERFORMED PRIOR TO TREATMENTS TO CONFIRM THE SYSTEM LASER IS PROVIDING CORRECT PATTERN/COVERAGE. THE USER FACILITY SAID THEY MIGHT CONSIDER PERFORMING THIS ACTION FOR FUTURE TREATMENTS. THE SYSTEM HAS SOFTWARE SAFEGUARDS (SUCH AS A POWER ON SELF-TEST) THAT WILL TRIGGER ERROR/EVENT CODES SHOULD THE SYSTEM BE OUTSIDE OF ACCEPTABLE LIMITS. THE CUSTOMER CAN ALSO UTILIZE THE BURN PAPER TO CONFIRM THE SYSTEM LASER IS PROVIDING THE CORRECT PATTERN/COVERAGE. THE CUSTOMER DID NOT PERFORM THE REQUESTED BURN PAPER TEST; THUS, PROPER PATTERN/COVERAGE CANNOT BE VERIFIED. IT IS THE RESPONSIBILITY OF THE CUSTOMER TO PERFORM THE BURN PAPER TEST AND SUBMIT IT FOR REVIEW. ACCORDING TO THE CLEAR + BRILLIANT USER MANUAL AND HAZARD ANALYSIS, BLISTERS AND PINPOINT BLEEDING ARE KNOWN POTENTIAL ADVERSE REACTIONS TO TREATMENT. PINPOINT BLEEDING/PETECHIAE ALTHOUGH RARE, MAY OCCUR AND TYPICALLY SELF-RESOLVE WITHOUT SEQUELAE. BASED ON THE AVAILABLE INFORMATION, NO CAUSAL FACTORS CAN BE DETERMINED, AND NO CONCLUSIONS CAN BE DRAWN. NO NON-CONFORMITIES OR ANOMALIES FOUND RELATED TO THIS COMPLAINT WHEN REVIEWING THE DEVICE HISTORY RECORD. THE LOT HISTORY, TREND ANALYSIS, RISK ANALYSIS AND DIRECTIONS FOR USE REVIEW WERE CONSIDERED ACCEPTABLE, WITH THE PRODUCT PERFORMING WITHIN ANTICIPATED RATES. AT THIS TIME, NO CAPA IS NECESSARY.
A USER FACILITY REPORTED THAT A PATIENT EXPERIENCED BLISTERS AND PINPOINT BLEEDING ON THE CHEEK ON THE EVENING FOLLOWING A CLEAR + BRILLIANT TREATMENT TO THE FACE. THE PATIENT WAS TREATED WITH AN UNKNOWN NUMBING CREAM. THE CURRENT STATUS AT THE TIME WAS REPORTED AS SCABBING. BASED UPON AN EVALUATION OF AVAILABLE PICTURES BY THE MEDICAL REVIEWER, THE FIRST PICTURE SHOWED ERYTHEMA AND INFLAMMATION ALL OVER THE FACE. ADDITIONAL PICTURES SHOWED PINPOINT BLEEDING AND SCABBING FORMATION ON ONE SIDE OF THE CHEEK. IT WAS REPORTED THAT THE PATIENT STOPPED RETINOL AND AHA/BHA PRODUCTS 3 WEEKS BEFORE THE TREATMENT. IT WAS ALSO CONFIRMED THAT THE PATIENT WAS NOT ON BLOOD THINNERS NOR DID DO THEY HAVE A DIAGNOSIS OF ANY AUTOIMMUNE SYSTEM DISORDERS. HOWEVER, THE PATIENT REPORTED TO THE USER FACILITY THAT SHE BURNS EASILY. THE USER FACILITY REPORTED THAT NO OTHER TREATMENTS (BESIDES THE ONE REPORTED) WERE BEING PERFORMED IN THE SAME AREA WHERE SYMPTOMS OCCURRED. THE PATIENT HAS UNDERGONE EXCEL V TREATMENT/ HALF FACE APPROXIMATELY 5 AND 6 MONTHS AGO. THE INCIDENT OCCURRED WITH 3 PASSES AT THE HIGHEST ENERGY OF 2 KJ. NO OTHER SYSTEM ERRORS OCCURRED OR WERE NOTICED DURING THE TREATMENT. THIS TREATMENT TIP HAS NOT BEEN USED ON OTHER PATIENTS. UPON A RECENT FOLLOW UP, THE USER FACILITY MENTIONED THAT NO FURTHER COMPLICATIONS OR UPDATES FROM THE PATIENT HAVE BEEN REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2125669 | CLEAR + BRILLIANT LASER SYSTEM | POWERED LASER SURGICAL INSTRUMENT WITH MICROBEAM | ONG | SOLTA MEDICAL, INC | CB-CONSOLE | 00850608002643 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female |